Cost Analysis of COPD: A Case Study in Düzce University Hospital

Basit Öğe Kaydı
dc.contributor.authorAkkol, Sevval
dc.contributor.authorBozdemir, Enver
dc.date.accessioned2025-10-11T20:47:58Z
dc.date.available2025-10-11T20:47:58Z
dc.date.issued2025
dc.departmentDüzce Üniversitesien_US
dc.description.abstractObjective: The aim of the study is to analyze the costs of Chronic Obstructive Pulmonary Disease (COPD) from the perspective of the Social Security Institution (SSI). Method: In the research, data obtained retrospectively using the qualitative method were subjected to document analysis. The study covers 241 COPD patients in 2022 in the Chest Diseases unit of D & uuml;zce University Health Application and Research Center/Hospital. No sample was selected in the research, but the entire population was used. Data were subjected to multivariate regression analysis. Costs include examinations, medical supplies, medications, imaging and laboratory tests. Results: Of 130 outpatients, 110 (85%) were male, 20 (15%) were female, the mean age was 66.82 years, and outpatient treatment cost was 127.76h ($7.72)/patient. Of the 111 inpatients, 88 (79%) were male, 23 (21%) were female, the mean age was 70.19 years, and the mean duration of hospitalization was 7.08 days. The average total treatment cost of the clinic was 2,319.64h ($140.16)/patient. Of this, 1,059.97 h ($64.05) was for intervention, 267.62 h ($16.17) for medical supplies, 907.74 h ($54.85) for medication, and 499.98 h ($30.21) for investigations. It was determined that the gender, age, and hospitalization duration of the patients changed the treatment costs (p<0.05). In addition, it was determined that the SSI incurred an average annual drug cost of 6,321.84 h ($381.98). A total annual average cost of 9,184.90 h ($554.98) /patient was determined. Conclusions: The study found that treating COPD is a significant economic burden per patient for the SSI. A significant portion of this cost is comprised of medication expenses. This increases the lifetime costs of COPD. In order to reduce the cost of the disease, both necessary measures should beAtaken to reduce the risk of developing the disease, and lower-cost methods should be followed in the treatment of the disease.en_US
dc.identifier.doi10.18521/ktd.1443887
dc.identifier.endpage175en_US
dc.identifier.issn1309-3878
dc.identifier.issue2en_US
dc.identifier.startpage166en_US
dc.identifier.trdizinid1321031en_US
dc.identifier.urihttps://doi.org/10.18521/ktd.1443887
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1321031
dc.identifier.urihttps://hdl.handle.net/20.500.12684/21662
dc.identifier.volume17en_US
dc.identifier.wosWOS:001520342200007en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherDuzce Univ, Fac Medicineen_US
dc.relation.ispartofKonuralp Tip Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmzKA_WOS_20250911
dc.subjectChest Diseasesen_US
dc.subjectCOPHen_US
dc.subjectCost of Diseaseen_US
dc.titleCost Analysis of COPD: A Case Study in Düzce University Hospitalen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu